Structure

Physi-Chem Properties

Molecular Weight:  369.3
Volume:  430.448
LogP:  8.461
LogD:  4.583
LogS:  -6.86
# Rotatable Bonds:  14
TPSA:  22.0
# H-Bond Aceptor:  2
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.323
Synthetic Accessibility Score:  2.167
Fsp3:  0.64
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.861
MDCK Permeability:  8.6194140749285e-06
Pgp-inhibitor:  0.184
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.604
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.373
Plasma Protein Binding (PPB):  98.50736236572266%
Volume Distribution (VD):  2.932
Pgp-substrate:  0.5293500423431396%

ADMET: Metabolism

CYP1A2-inhibitor:  0.171
CYP1A2-substrate:  0.198
CYP2C19-inhibitor:  0.392
CYP2C19-substrate:  0.109
CYP2C9-inhibitor:  0.107
CYP2C9-substrate:  0.953
CYP2D6-inhibitor:  0.24
CYP2D6-substrate:  0.579
CYP3A4-inhibitor:  0.285
CYP3A4-substrate:  0.086

ADMET: Excretion

Clearance (CL):  4.314
Half-life (T1/2):  0.032

ADMET: Toxicity

hERG Blockers:  0.227
Human Hepatotoxicity (H-HT):  0.048
Drug-inuced Liver Injury (DILI):  0.283
AMES Toxicity:  0.584
Rat Oral Acute Toxicity:  0.08
Maximum Recommended Daily Dose:  0.359
Skin Sensitization:  0.96
Carcinogencity:  0.057
Eye Corrosion:  0.016
Eye Irritation:  0.973
Respiratory Toxicity:  0.546

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC258531

Natural Product ID:  NPC258531
Common Name*:   1-Methyl-2-Pentadecylquinolin-4-One
IUPAC Name:   1-methyl-2-pentadecylquinolin-4-one
Synonyms:  
Standard InCHIKey:  YOXIQBPUPGISEN-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H39NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-22-21-25(27)23-19-16-17-20-24(23)26(22)2/h16-17,19-21H,3-15,18H2,1-2H3
SMILES:  CCCCCCCCCCCCCCCc1cc(=O)c2ccccc2n1C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1643844
PubChem CID:   5319753
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0000056] Quinolones and derivatives
          • [CHEMONTID:0001716] Hydroquinolones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[7463094]
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[8201313]
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[8699182]
NPO30823 Evodia rutaecarpa n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO30823 Evodia rutaecarpa n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO19935 Evodia rutaecarpa Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens Activity = 57.9 % PMID[536071]
NPT171 Cell Line MRC5 Homo sapiens Activity = 79.8 % PMID[536071]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis MIC = 346900.0 nM PMID[536071]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC258531 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC112373
1.0 High Similarity NPC161956
0.9911 High Similarity NPC177684
0.9911 High Similarity NPC291962
0.9565 High Similarity NPC257490
0.9397 High Similarity NPC103292
0.9316 High Similarity NPC39818
0.931 High Similarity NPC279385
0.931 High Similarity NPC179605
0.8583 High Similarity NPC226143
0.8374 Intermediate Similarity NPC268534
0.8348 Intermediate Similarity NPC172170
0.8308 Intermediate Similarity NPC300299
0.8134 Intermediate Similarity NPC471574
0.8125 Intermediate Similarity NPC209389
0.8083 Intermediate Similarity NPC57051
0.8062 Intermediate Similarity NPC194562
0.8031 Intermediate Similarity NPC470343
0.8031 Intermediate Similarity NPC472244
0.8016 Intermediate Similarity NPC254698
0.8 Intermediate Similarity NPC471164
0.7956 Intermediate Similarity NPC136002
0.7852 Intermediate Similarity NPC83214
0.7846 Intermediate Similarity NPC150863
0.782 Intermediate Similarity NPC162417
0.782 Intermediate Similarity NPC316104
0.7812 Intermediate Similarity NPC192533
0.7801 Intermediate Similarity NPC144691
0.7794 Intermediate Similarity NPC207554
0.7786 Intermediate Similarity NPC472245
0.7786 Intermediate Similarity NPC314431
0.7786 Intermediate Similarity NPC280807
0.7727 Intermediate Similarity NPC316746
0.7669 Intermediate Similarity NPC207428
0.7609 Intermediate Similarity NPC2823
0.7448 Intermediate Similarity NPC117032
0.7426 Intermediate Similarity NPC253476
0.741 Intermediate Similarity NPC315051
0.7407 Intermediate Similarity NPC53044
0.7383 Intermediate Similarity NPC27904
0.7383 Intermediate Similarity NPC93653
0.7372 Intermediate Similarity NPC173295
0.7324 Intermediate Similarity NPC470822
0.7324 Intermediate Similarity NPC130797
0.7286 Intermediate Similarity NPC472243
0.7279 Intermediate Similarity NPC295021
0.7273 Intermediate Similarity NPC167336
0.7254 Intermediate Similarity NPC308197
0.7237 Intermediate Similarity NPC299582
0.7161 Intermediate Similarity NPC318183
0.7133 Intermediate Similarity NPC478040
0.7132 Intermediate Similarity NPC187231
0.7123 Intermediate Similarity NPC300596
0.7123 Intermediate Similarity NPC237649
0.7123 Intermediate Similarity NPC242000
0.7113 Intermediate Similarity NPC43477
0.7113 Intermediate Similarity NPC316202
0.7111 Intermediate Similarity NPC58827
0.7111 Intermediate Similarity NPC72473
0.7111 Intermediate Similarity NPC307437
0.7103 Intermediate Similarity NPC324445
0.7092 Intermediate Similarity NPC469560
0.7083 Intermediate Similarity NPC314186
0.708 Intermediate Similarity NPC314098
0.7063 Intermediate Similarity NPC472241
0.7059 Intermediate Similarity NPC122235
0.7042 Intermediate Similarity NPC130251
0.7037 Intermediate Similarity NPC250476
0.7029 Intermediate Similarity NPC40364
0.7025 Intermediate Similarity NPC291610
0.7021 Intermediate Similarity NPC122553
0.7014 Intermediate Similarity NPC314287
0.7007 Intermediate Similarity NPC477432
0.7 Intermediate Similarity NPC75496
0.7 Intermediate Similarity NPC313449
0.6993 Remote Similarity NPC301760
0.6987 Remote Similarity NPC472118
0.6986 Remote Similarity NPC478039
0.6974 Remote Similarity NPC154478
0.6957 Remote Similarity NPC231382
0.6954 Remote Similarity NPC84317
0.695 Remote Similarity NPC471123
0.6948 Remote Similarity NPC138293
0.6948 Remote Similarity NPC113056
0.6948 Remote Similarity NPC204867
0.6918 Remote Similarity NPC472242
0.6911 Remote Similarity NPC38262
0.6894 Remote Similarity NPC85613
0.6889 Remote Similarity NPC226794
0.6883 Remote Similarity NPC293458
0.687 Remote Similarity NPC192209
0.6855 Remote Similarity NPC469529
0.6846 Remote Similarity NPC288232
0.6846 Remote Similarity NPC13526
0.6835 Remote Similarity NPC292265
0.6822 Remote Similarity NPC296163
0.6822 Remote Similarity NPC187036
0.6818 Remote Similarity NPC228515
0.6813 Remote Similarity NPC471743
0.6813 Remote Similarity NPC475607
0.6807 Remote Similarity NPC256452
0.6795 Remote Similarity NPC471130
0.679 Remote Similarity NPC5167
0.6788 Remote Similarity NPC322433
0.6774 Remote Similarity NPC469741
0.6774 Remote Similarity NPC88970
0.6772 Remote Similarity NPC471943
0.677 Remote Similarity NPC474081
0.6757 Remote Similarity NPC470579
0.675 Remote Similarity NPC475594
0.6746 Remote Similarity NPC55529
0.673 Remote Similarity NPC355
0.6723 Remote Similarity NPC291070
0.6723 Remote Similarity NPC246757
0.6716 Remote Similarity NPC130931
0.6688 Remote Similarity NPC123241
0.6667 Remote Similarity NPC253667
0.6667 Remote Similarity NPC326792
0.6667 Remote Similarity NPC469537
0.6667 Remote Similarity NPC35510
0.6646 Remote Similarity NPC279527
0.6646 Remote Similarity NPC214960
0.6643 Remote Similarity NPC179224
0.6627 Remote Similarity NPC476341
0.6626 Remote Similarity NPC474041
0.6626 Remote Similarity NPC475761
0.6626 Remote Similarity NPC475094
0.6624 Remote Similarity NPC265100
0.6624 Remote Similarity NPC189116
0.6623 Remote Similarity NPC473329
0.6614 Remote Similarity NPC20322
0.661 Remote Similarity NPC78154
0.6606 Remote Similarity NPC470317
0.6604 Remote Similarity NPC475248
0.6604 Remote Similarity NPC63047
0.6603 Remote Similarity NPC315368
0.6594 Remote Similarity NPC79698
0.6593 Remote Similarity NPC316582
0.6585 Remote Similarity NPC475685
0.6585 Remote Similarity NPC73994
0.6582 Remote Similarity NPC115232
0.6581 Remote Similarity NPC113946
0.6579 Remote Similarity NPC314223
0.6579 Remote Similarity NPC154602
0.6579 Remote Similarity NPC243756
0.6564 Remote Similarity NPC83774
0.6561 Remote Similarity NPC242116
0.6561 Remote Similarity NPC472117
0.6558 Remote Similarity NPC114808
0.6543 Remote Similarity NPC470548
0.6541 Remote Similarity NPC114637
0.6536 Remote Similarity NPC285381
0.6536 Remote Similarity NPC122106
0.6531 Remote Similarity NPC470301
0.6529 Remote Similarity NPC1820
0.65 Remote Similarity NPC476950
0.65 Remote Similarity NPC167724
0.65 Remote Similarity NPC70949
0.65 Remote Similarity NPC223595
0.65 Remote Similarity NPC224970
0.6486 Remote Similarity NPC238499
0.6485 Remote Similarity NPC283810
0.6485 Remote Similarity NPC61011
0.6485 Remote Similarity NPC298320
0.6484 Remote Similarity NPC79618
0.6474 Remote Similarity NPC61013
0.6474 Remote Similarity NPC104345
0.6471 Remote Similarity NPC313293
0.6471 Remote Similarity NPC66936
0.6463 Remote Similarity NPC284775
0.6463 Remote Similarity NPC242933
0.6456 Remote Similarity NPC476231
0.6456 Remote Similarity NPC214106
0.6434 Remote Similarity NPC164802
0.6433 Remote Similarity NPC193410
0.6433 Remote Similarity NPC36495
0.6429 Remote Similarity NPC2785
0.6429 Remote Similarity NPC285470
0.6429 Remote Similarity NPC70406
0.6429 Remote Similarity NPC36342
0.6429 Remote Similarity NPC202613
0.6424 Remote Similarity NPC467188
0.6419 Remote Similarity NPC22082
0.6419 Remote Similarity NPC186284
0.6415 Remote Similarity NPC313757
0.641 Remote Similarity NPC29285
0.6395 Remote Similarity NPC319645
0.6392 Remote Similarity NPC248117
0.6392 Remote Similarity NPC472102
0.6392 Remote Similarity NPC309531
0.6392 Remote Similarity NPC474058
0.6391 Remote Similarity NPC472164
0.6391 Remote Similarity NPC113099
0.6387 Remote Similarity NPC281094
0.6387 Remote Similarity NPC251391
0.6387 Remote Similarity NPC478076
0.6372 Remote Similarity NPC300205
0.6369 Remote Similarity NPC46895
0.6369 Remote Similarity NPC21429
0.6364 Remote Similarity NPC126458

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC258531 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8571 High Similarity NPD486 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD441 Approved
0.8347 Intermediate Similarity NPD1668 Clinical (unspecified phase)
0.8162 Intermediate Similarity NPD6017 Discontinued
0.8154 Intermediate Similarity NPD2949 Approved
0.8154 Intermediate Similarity NPD2950 Approved
0.8154 Intermediate Similarity NPD1527 Phase 2
0.8077 Intermediate Similarity NPD1919 Approved
0.8077 Intermediate Similarity NPD1920 Approved
0.7949 Intermediate Similarity NPD1065 Approved
0.7949 Intermediate Similarity NPD1064 Approved
0.791 Intermediate Similarity NPD6342 Discontinued
0.7879 Intermediate Similarity NPD1541 Approved
0.7879 Intermediate Similarity NPD6740 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD797 Clinical (unspecified phase)
0.7795 Intermediate Similarity NPD4775 Clinical (unspecified phase)
0.7787 Intermediate Similarity NPD1175 Approved
0.7681 Intermediate Similarity NPD6513 Approved
0.7681 Intermediate Similarity NPD6512 Approved
0.7674 Intermediate Similarity NPD1640 Clinical (unspecified phase)
0.7518 Intermediate Similarity NPD5931 Phase 3
0.7518 Intermediate Similarity NPD5933 Phase 3
0.7518 Intermediate Similarity NPD5932 Phase 3
0.7483 Intermediate Similarity NPD4942 Approved
0.7466 Intermediate Similarity NPD4042 Phase 2
0.7466 Intermediate Similarity NPD4045 Phase 2
0.7458 Intermediate Similarity NPD708 Approved
0.7448 Intermediate Similarity NPD3248 Phase 1
0.7447 Intermediate Similarity NPD5918 Discontinued
0.7442 Intermediate Similarity NPD1124 Approved
0.7442 Intermediate Similarity NPD1123 Approved
0.7429 Intermediate Similarity NPD6768 Approved
0.7429 Intermediate Similarity NPD3482 Approved
0.7422 Intermediate Similarity NPD1306 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD1100 Approved
0.7414 Intermediate Similarity NPD1099 Approved
0.7388 Intermediate Similarity NPD2918 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD2919 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD5180 Approved
0.736 Intermediate Similarity NPD5181 Approved
0.736 Intermediate Similarity NPD5179 Approved
0.7338 Intermediate Similarity NPD1626 Approved
0.7324 Intermediate Similarity NPD3481 Approved
0.7324 Intermediate Similarity NPD4043 Approved
0.7324 Intermediate Similarity NPD4046 Approved
0.7311 Intermediate Similarity NPD2193 Phase 2
0.7311 Intermediate Similarity NPD2648 Phase 3
0.7305 Intermediate Similarity NPD6566 Discontinued
0.7279 Intermediate Similarity NPD2790 Discontinued
0.7267 Intermediate Similarity NPD2506 Approved
0.7246 Intermediate Similarity NPD1410 Phase 1
0.7246 Intermediate Similarity NPD2331 Discontinued
0.7241 Intermediate Similarity NPD4939 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD1874 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD3546 Approved
0.7213 Intermediate Similarity NPD3545 Approved
0.7192 Intermediate Similarity NPD2737 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD4549 Discontinued
0.7167 Intermediate Similarity NPD813 Approved
0.7167 Intermediate Similarity NPD2196 Discontinued
0.7167 Intermediate Similarity NPD2171 Approved
0.7154 Intermediate Similarity NPD4115 Approved
0.7154 Intermediate Similarity NPD4114 Approved
0.7133 Intermediate Similarity NPD2820 Phase 3
0.7133 Intermediate Similarity NPD1625 Approved
0.7132 Intermediate Similarity NPD5131 Approved
0.7131 Intermediate Similarity NPD2197 Approved
0.7131 Intermediate Similarity NPD2192 Approved
0.7123 Intermediate Similarity NPD4888 Discontinued
0.7122 Intermediate Similarity NPD2791 Discontinued
0.7113 Intermediate Similarity NPD3434 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD1342 Approved
0.7092 Intermediate Similarity NPD6655 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD7254 Discontinued
0.7086 Intermediate Similarity NPD2427 Approved
0.7078 Intermediate Similarity NPD4645 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD5227 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD2365 Approved
0.7063 Intermediate Similarity NPD6414 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1781 Discontinued
0.7045 Intermediate Similarity NPD1079 Discontinued
0.704 Intermediate Similarity NPD4116 Approved
0.7032 Intermediate Similarity NPD2037 Approved
0.7025 Intermediate Similarity NPD4735 Approved
0.7025 Intermediate Similarity NPD4734 Approved
0.7021 Intermediate Similarity NPD2670 Approved
0.7 Intermediate Similarity NPD7481 Approved
0.7 Intermediate Similarity NPD7072 Phase 2
0.7 Intermediate Similarity NPD7480 Approved
0.6993 Remote Similarity NPD4461 Discontinued
0.6987 Remote Similarity NPD3376 Clinical (unspecified phase)
0.698 Remote Similarity NPD1854 Approved
0.6974 Remote Similarity NPD33 Approved
0.6974 Remote Similarity NPD4393 Approved
0.6972 Remote Similarity NPD7142 Discontinued
0.6963 Remote Similarity NPD1574 Approved
0.6957 Remote Similarity NPD2754 Discontinued
0.6957 Remote Similarity NPD1619 Phase 3
0.6957 Remote Similarity NPD1190 Approved
0.6954 Remote Similarity NPD6855 Clinical (unspecified phase)
0.6944 Remote Similarity NPD1189 Approved
0.694 Remote Similarity NPD1360 Approved
0.6939 Remote Similarity NPD7088 Discontinued
0.6937 Remote Similarity NPD3782 Discontinued
0.6929 Remote Similarity NPD3001 Approved
0.6929 Remote Similarity NPD2999 Approved
0.6917 Remote Similarity NPD678 Discontinued
0.6912 Remote Similarity NPD1593 Approved
0.6911 Remote Similarity NPD2577 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7633 Discontinued
0.6905 Remote Similarity NPD3548 Approved
0.6901 Remote Similarity NPD6358 Phase 2
0.6897 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6897 Remote Similarity NPD4430 Phase 2
0.6897 Remote Similarity NPD7082 Approved
0.6894 Remote Similarity NPD4330 Approved
0.6894 Remote Similarity NPD1217 Clinical (unspecified phase)
0.6894 Remote Similarity NPD4329 Approved
0.6889 Remote Similarity NPD9541 Approved
0.6889 Remote Similarity NPD9539 Approved
0.688 Remote Similarity NPD5253 Approved
0.6879 Remote Similarity NPD2470 Clinical (unspecified phase)
0.6879 Remote Similarity NPD2369 Discontinued
0.6875 Remote Similarity NPD1222 Discontinued
0.6875 Remote Similarity NPD2010 Phase 3
0.6875 Remote Similarity NPD3792 Approved
0.6871 Remote Similarity NPD8241 Phase 2
0.6855 Remote Similarity NPD1677 Discontinued
0.6849 Remote Similarity NPD7487 Discontinued
0.6849 Remote Similarity NPD7259 Approved
0.6846 Remote Similarity NPD5748 Phase 2
0.6835 Remote Similarity NPD4300 Clinical (unspecified phase)
0.6835 Remote Similarity NPD2431 Approved
0.6835 Remote Similarity NPD2432 Approved
0.6822 Remote Similarity NPD2913 Approved
0.6822 Remote Similarity NPD3387 Approved
0.6822 Remote Similarity NPD2914 Approved
0.6821 Remote Similarity NPD7612 Clinical (unspecified phase)
0.6815 Remote Similarity NPD2455 Approved
0.6815 Remote Similarity NPD2454 Approved
0.6813 Remote Similarity NPD2083 Clinical (unspecified phase)
0.6803 Remote Similarity NPD7295 Approved
0.6797 Remote Similarity NPD6019 Approved
0.6797 Remote Similarity NPD5659 Approved
0.6797 Remote Similarity NPD5660 Approved
0.6797 Remote Similarity NPD6018 Approved
0.6794 Remote Similarity NPD6070 Approved
0.6794 Remote Similarity NPD6069 Approved
0.6791 Remote Similarity NPD3836 Clinical (unspecified phase)
0.6788 Remote Similarity NPD9540 Approved
0.6788 Remote Similarity NPD2840 Approved
0.6783 Remote Similarity NPD4077 Clinical (unspecified phase)
0.6757 Remote Similarity NPD1524 Phase 1
0.6753 Remote Similarity NPD6629 Discontinued
0.6746 Remote Similarity NPD6299 Approved
0.6746 Remote Similarity NPD6300 Approved
0.6739 Remote Similarity NPD5993 Phase 1
0.6732 Remote Similarity NPD2351 Discontinued
0.6732 Remote Similarity NPD951 Approved
0.6718 Remote Similarity NPD1323 Discontinued
0.6711 Remote Similarity NPD7478 Approved
0.6711 Remote Similarity NPD7794 Clinical (unspecified phase)
0.671 Remote Similarity NPD5992 Approved
0.6709 Remote Similarity NPD2404 Discontinued
0.6694 Remote Similarity NPD4655 Approved
0.6694 Remote Similarity NPD4657 Approved
0.6694 Remote Similarity NPD3357 Discontinued
0.6693 Remote Similarity NPD1721 Clinical (unspecified phase)
0.6692 Remote Similarity NPD5657 Phase 3
0.6689 Remote Similarity NPD1230 Approved
0.6687 Remote Similarity NPD3377 Discontinued
0.6667 Remote Similarity NPD3865 Approved
0.6667 Remote Similarity NPD4094 Approved
0.6667 Remote Similarity NPD979 Approved
0.6667 Remote Similarity NPD990 Approved
0.6667 Remote Similarity NPD479 Approved
0.6667 Remote Similarity NPD7528 Approved
0.6667 Remote Similarity NPD993 Approved
0.6647 Remote Similarity NPD4988 Discontinued
0.6646 Remote Similarity NPD3471 Approved
0.6646 Remote Similarity NPD3422 Phase 3
0.6646 Remote Similarity NPD3470 Approved
0.6646 Remote Similarity NPD3423 Phase 2
0.6644 Remote Similarity NPD3278 Clinical (unspecified phase)
0.6641 Remote Similarity NPD5631 Phase 3
0.6624 Remote Similarity NPD2288 Clinical (unspecified phase)
0.6623 Remote Similarity NPD2836 Approved
0.6621 Remote Similarity NPD3170 Approved
0.6614 Remote Similarity NPD1054 Approved
0.6613 Remote Similarity NPD6024 Approved
0.6613 Remote Similarity NPD6027 Approved
0.66 Remote Similarity NPD1801 Approved
0.66 Remote Similarity NPD1802 Approved
0.6596 Remote Similarity NPD1070 Approved
0.6596 Remote Similarity NPD1069 Approved
0.6594 Remote Similarity NPD5136 Clinical (unspecified phase)
0.6584 Remote Similarity NPD7443 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7606 Phase 3
0.6573 Remote Similarity NPD1531 Approved
0.6569 Remote Similarity NPD3623 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data